Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $) | | |
In Thousands | 3 Months Ended
Mar. 31, 2010
| 3 Months Ended
Mar. 31, 2009
|
Cash flows from operating activities: | | |
Consolidated net income (loss) | $164,610 | ($4,460) |
Adjustments to reconcile net income (loss) to net cash from operating activities: | | |
Depreciation and amortization | 35,269 | 37,536 |
Share-based compensation | 40,561 | 33,562 |
Loss on equity investment | 0 | 1,686 |
Excess tax benefits from share-based compensation | (20,520) | (3,110) |
Deferred income taxes | (12,471) | 48,438 |
Changes in operating assets and liabilities: | | |
Accounts receivable, net | 55,718 | 68,012 |
Prepaid expenses and other assets | (11,150) | 8,312 |
Accounts payable | (14,125) | (39,224) |
Accrued compensation | (19,847) | (31,720) |
Accrued litigation settlements | (169,330) | 0 |
Income tax payable | (1,088) | 19,307 |
Other accrued liabilities | 4,620 | 3,442 |
Deferred revenue | 36,299 | 22,084 |
Net cash provided by operating activities | 88,546 | 163,865 |
Cash flows from investing activities: | | |
Purchases of property and equipment, net | (37,807) | (34,226) |
Purchases of trading investments | (1,245) | 0 |
Purchases of available-for-sale investments | (447,716) | (109,290) |
Proceeds from sales of available-for-sale investments | 224,514 | 62,401 |
Proceeds from maturities of available-for-sale investments | 235,960 | 16,850 |
Changes in restricted cash | (1,550) | 0 |
(Purchases of) proceeds from privately-held equity investments, net | (4,773) | 1,013 |
Net cash used in investing activities | (32,617) | (63,252) |
Cash flows from financing activities: | | |
Proceeds from issuance of common stock | 118,920 | 22,628 |
Purchases and retirement of common stock | (76,225) | (119,846) |
Net proceeds from (payments for) customer financing arrangements | 2,082 | (20,606) |
Excess tax benefits from share-based compensation | 20,520 | 3,110 |
Return of capital to noncontrolling interest | (2,000) | 0 |
Net cash provided by (used in) financing activities | 63,297 | (114,714) |
Net increase (decrease) in cash and cash equivalents | 119,226 | (14,101) |
Cash and cash equivalents at beginning of period | 1,604,723 | 2,019,084 |
Cash and cash equivalents at end of period | $1,723,949 | $2,004,983 |